ReShape Lifesciences Inc.

-0.08 (-15.38%)
7:59:51 PM EDT: $0.48 +0.04 (+9.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.52M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.4 Million
Adjusted EPS-$1.20
See more estimates
10-Day MA$0.61
50-Day MA$1.06
200-Day MA$3.31
See more pivots

ReShape Lifesciences Inc. Stock, NASDAQ:RSLS

1001 Calle Amanecer, San Clemente, California 92673
United States of America
Phone: +1.949.429.6680
Number of Employees: 40


ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates though the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.